Non ci sono recensioni
This book provides clinicians with the information needed to effectively interpret the literature from observational and interventional cardiovascular outcomes studies. The book begins by providing a historical context of cardiovascular epidemiology, followed by chapters addressing key concepts in the study of cardiovascular disease such as the types of cardiovascular outcomes studies, basic and evolving design and statistical considerations, current guidelines for reducing atherosclerotic cardiovascular disease risk, surrogate markers of cardiovascular disease, challenges in developing evidence-based recommendations for non-pharmacological interventions, an overview of the pharmaceutical development process, and a detailed discussion of the clinical evidence supporting several factors and their relationships with atherosclerotic cardiovascular disease (lipids, inflammation, hemostasis, heart rhythm, blood pressure, diabetes, obesity, and chronic kidney disease).
Cardiovascular Outcomes Research is a must-have resource for physicians and other clinicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention.
Front Matter
Pages i-xvi
Background and Process
Front Matter
Pages 1-1
Evolution of Cardiovascular Outcomes Studies
Liana L. Guarneiri, Mary R. Dicklin, Kevin C. Maki
Pages 3-18
Statistical Methods for Cardiovascular Outcomes Studies
Aurelian Bidulescu, Steven R. Horbal, Andrew D. Althouse
Pages 19-66
Pharmaceutical Development and Approval in the United States of Agents to Influence Cardiovascular Health
Mary Katherine Cheeley, Laurie Cavendish
Pages 67-81
Biomarkers and Imaging Modalities to Detect Subclinical Atherosclerotic Cardiovascular Disease
Catherine J. McNeal, Philip D. Houck, Nguyen N. Nguyen, James Murchison, Harry Chiang
Pages 83-110
An Overview of the Guideline Development Process for Atherosclerotic Cardiovascular Disease Risk Reduction with an Emphasis on Guidelines for Cholesterol and Dyslipidemia Management
Carl E. Orringer
Pages 111-116
Implementation Science: Strategies to Improve Adoption and Adherence to Clinical Practice Guidelines
Laney K. Jones, Mitchell N. Sarkies, Michael R. Gionfriddo, Samuel S. Gidding, Gerald F. Watts
Pages 117-141
Challenges in Developing Evidence-Based Recommendations for Non-Pharmacological Interventions for Atherosclerotic Cardiovascular Disease Risk Reduction
Kristina S. Petersen
Pages 143-164
Overview of Current Evidence in Categories of Interventions
Front Matter
Pages 165-165
Download chapter PDF
Lifestyle Interventions and Atherosclerotic Cardiovascular Disease Outcomes
Carol F. Kirkpatrick, Kathyrn A. Greaves, Elaine Foster
Pages 167-200
Lipids, Lipoproteins, and Cardiovascular Outcomes
Alexander Sakers, Reed Mszar, Daniel Soffer
Pages 201-236
Inflammation and Cardiovascular Outcomes
Priyanka Satish, Anandita Agarwala
Pages 237-260
Thrombosis, Hemostasis, and Cardiovascular Outcomes
Agastya D. Belur, Shengnan Zheng, Munis Raza, Dinesh K. Kalra
Pages 261-301
Blood Pressure and Cardiovascular Outcomes
Steven A. Greenstein, Joseph A. Diamond
Pages 303-318
Pharmacotherapy for Obesity: Recent Evolution and Implications for Cardiovascular Risk Reduction
Kevin C. Maki, Carol F. Kirkpatrick, David B. Allison, Kishore M. Gadde
Pages 319-343
Cardiovascular Disease Risk and Risk Reduction Strategies in Diabetes Mellitus
Don P. Wilson, Luke Hamilton, Kevin C. Maki
Pages 345-371
Cardiac Rhythms and Cardiovascular Outcomes
Bahij Kreidieh, Ali Keramati, Peter R. Kowey
Pages 373-400
Chronic Kidney Disease and Cardiovascular Outcomes
Gates B. Colbert, Lovy Gaur, Mohamed Elrggal, Hector Madariaga, Edgar Lerma
Pages 401-429
Back Matter
Pages 431-438
Sei sicuro di voler eseguire questa azione?